Literature DB >> 6692595

Quantitative determination of complement components produced by purified hepatocytes.

G Ramadori, H Rasokat, R Burger, K H Meyer Zum Büschenfelde, D Bitter-Suermann.   

Abstract

In this report we describe, on a quantitative basis, the secretion of complement components by hepatocytes. Primary cultures were established after isolation of the cells from guinea-pig liver and the synthesis of C3, C5, C4 and C2 was measured. The cells were isolated by collagenase perfusion of the liver followed by differential centrifugation. The contamination of the hepatocyte suspension with non-parenchymal cells was less than 1%. At 24 h after plating the cells the kinetics of complement production were measured. C3 and C5 content in the culture medium harvested at different time intervals was determined by a sensitive ELISA. Secretion of C2 and C4 was measured haemolytically using C2 or C4 deficient guinea-pig serum. Under the conditions used hepatocytes secreted C3 at a rate of about 100 ng/10(6) cells/h with a plateau of secretion after 24 h of culture corresponding to about 350,000 molecules/cell/h. C5 secretion was detectable after 3-6 h of culture. The C5 secretion rate was about 15 ng/10(6) cells/24 h. The functional activity of C4 and C2 in the supernatants amounted to about 80 SFU/cell/h if the culture medium was changed every 3 h but dropped significantly if the medium was changed every 12 h. The decrease of the haemolytic activity became stronger if the medium was changed every 24 h. Cycloheximide reversibly inhibited the complement production. Our results show that guinea-pig hepatocytes synthesize considerably more C3 and C5 compared to peritoneal macrophages supporting the hypothesis that hepatocytes provide the major source of plasma complement.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6692595      PMCID: PMC1535773     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  The investigation of sinusoidal cells: a new approach to the study of liver function.

Authors:  E Wisse; D L Knook
Journal:  Prog Liver Dis       Date:  1979

2.  Distinct genes for fibroblast and serum C1q.

Authors:  J Skok; E Solomon; K B Reid; R A Thompson
Journal:  Nature       Date:  1981-08-06       Impact factor: 49.962

3.  Effects of polyribonoinosinic acid polyribocytidylic acid and a mouse interferon preparation on cytochrome P-450-dependent monooxygenase systems in cultures of primary mouse hepatocytes.

Authors:  K W Renton; L B Deloria; G J Mannering
Journal:  Mol Pharmacol       Date:  1978-07       Impact factor: 4.436

4.  Control of complement synthesis and secretion in bronchoalveolar and peritoneal macrophages.

Authors:  F S Cole; W J Matthews; J T Marino; D J Gash; H R Colten
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

5.  Biosynthesis of complement components.

Authors:  G Fey; H R Colten
Journal:  Fed Proc       Date:  1981-05-15

6.  Platelet-serotonin release by C3a and C5a: two independent pathways of activation.

Authors:  S Meuer; U Ecker; U Hadding; D Bitter-Suermann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Biosynthesis and processing of a human precursor complement protein, pro-C3, in a hepatoma-derived cell line.

Authors:  K M Morris; G Goldberger; H R Colten; D P Aden; B B Knowles
Journal:  Science       Date:  1982-01-22       Impact factor: 47.728

8.  Quantitative studies of the secretion of complement component C3 by resident, elicited and activated macrophages. Comparison with C2, C4 and lysosomal enzyme release.

Authors:  B Zimmer; H P Hartung; G Scharfenberger; D Bitter-Suermann; U Hadding
Journal:  Eur J Immunol       Date:  1982-05       Impact factor: 5.532

9.  Complement biosynthesis by the human hepatoma-derived cell line HepG2.

Authors:  K M Morris; D P Aden; B B Knowles; H R Colten
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

10.  The first component of complement. A quantitative comparison of its biosynthesis in culture by human epithelial and mesenchymal cells.

Authors:  K M Morris; H R Colten; D H Bing
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

2.  Biosynthesis and secretion of the third component of complement by human endothelial cells in vitro.

Authors:  A Ueki; T Sai; H Oka; M Tabata; K Hosokawa; Y Mochizuki
Journal:  Immunology       Date:  1987-05       Impact factor: 7.397

3.  The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells.

Authors:  Ching-Chuan Hsieh; Hong-Shiue Chou; Horng-Ren Yang; Feng Lin; Sumantha Bhatt; Jie Qin; Lianfu Wang; John J Fung; Shiguang Qian; Lina Lu
Journal:  Blood       Date:  2013-01-08       Impact factor: 22.113

4.  Biosynthesis of the third component of complement in rat liver epithelial cell lines and its stimulation by effector molecules from cultured human mononuclear cells.

Authors:  M Guiguet; M F Exilie Frigere; M C Dethieux; Y Bidan; G Mack
Journal:  In Vitro Cell Dev Biol       Date:  1987-12

Review 5.  Type 1 diabetes and engineering enhanced islet transplantation.

Authors:  Abiramy Jeyagaran; Chuan-En Lu; Aline Zbinden; Andreas L Birkenfeld; Sara Y Brucker; Shannon L Layland
Journal:  Adv Drug Deliv Rev       Date:  2022-08-21       Impact factor: 17.873

6.  Long-term biosynthesis of complement component C3 and alpha-1 acid glycoprotein by adult rat hepatocytes in a co-culture system with an epithelial liver cell-type.

Authors:  J P Lebreton; M Daveau; M Hiron; M Fontaine; D Biou; D Gilbert; C Guguen-Guillouzo
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

7.  Glomerular injury in end-stage liver disease--role of circulating IgG and IgM immune complexes.

Authors:  L S Milner; M T Houser; P C Kolbeck; D L Antonson; T L McDonald; R S Markin; B W Shaw
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

8.  Antibody-directed complement-mediated cytotoxicity to hepatocytes from patients with chronic hepatitis B.

Authors:  T I Michalak; J Y Lau; B M McFarlane; G J Alexander; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

Review 9.  Complement and macrophage crosstalk during process of angiogenesis in tumor progression.

Authors:  M Afzal Khan; A M Assiri; D C Broering
Journal:  J Biomed Sci       Date:  2015-07-22       Impact factor: 8.410

10.  Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1.

Authors:  G Ramadori; J D Sipe; C A Dinarello; S B Mizel; H R Colten
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.